1Huang D,Shi FD,Giscombe R,et al.Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis[J].Eur J Immunol,2001,31(1):225-232.
3Liu R,Zhou Q,La Cava A,et al.Expansion of regulatory T cells via IL-2/anti-IL-2 mAb complexes suppresses experimental myasthenia[J].Eur J Immunol,2010,40(6):1577-1589.
4Li X,Xiao BG,Xi JY,et al.Decrease of CD4(+)CD25(high)Foxp3(+) regulatory T cells and elevation of CD19(+)BAFF-R(+) B cells and soluble ICAM-1 in myasthenia gravis[J].Clin Immunol,2008,126(2):180-188.
5Link H,Xiao BG.Rat models as tool to develop new immune otherapies[J].Immunol Rev,2001,184:117-128.
6Ostlie N,Milani M,Wang W,et al.Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice[J].J Immunol,2003,170(1):604-612.
7Poussin MA,Goluszko E,Franco JU,et al.Role of IL-5 during primary and secondary immune response to acetylcholine receptor[J].J Neuroimmunol,2002,125(1-2):51-58.
8Sassano P,Paparo F,Ramieri V,et al.Interleukine-6 (IL-6) may be a link between myasthenia gravis and myoepithelioma of the parotid gland[J].Med Hypotheses,2007,68(2):314-317.
2Anlar B,Senbil N,Kose G,et al.Serological follow-up in juvenile myasthenia:clinical and acetylcholine receptor antibody status of patients followed for at least 2 years[J].Neuromuscul Dis,2005;15(1):355-7.
3Matusevicuis D,Navikas V,Palasik W,et al.Tumor necrosis factor-alpha,lymphotoxin,interleukin (IL)-6,IL-10,IL-12 and perforin mRNA expression in mononuclear cells in response to acetylcholine receptor is augmented in myasthenia gravis[J].Neuroimmunol,1996;71(1):191-8.
4Mocchegiani E,Giacconi R,Muzzioli M,et al.Different age-related effects of thymectomy in myasthenia gravis:role of thymoma,zinc,thymulin,IL-2 and IL-6[J].Mech Ageing Dev,2000;117(1):79-91.
5Bongioanni P,Ricciardi R,Romano MR.T-lymphocyte interferon-gamma receptor binding in patients with myasthenia gravis[J].Arch Neurol,1999;56(8):933-8.
6Vieweg J,Jackson A.Modulation of antitumor responses by dendritic cells[J].Springer Semin Immunopathol,2005;26(3):329-41.
7Shimizu K,Thomas EK,Giedlin M,et al.Enhancement of tumor lysate-and peptide-pulsed dendritic cell-based vaccines by the addition of foreign helper protein[J].Cancer Res,2001;61(6):2618-24.
8Schneider P,Tschopp J.BAFF and the regulation of B cell survival[J].Immunol Lett,2003;88(1):57-62.
9Huard B,Schneider P,Mauri D,et al.T cell costimulation by the TNF ligand BAFF[J].J Immunol,2001;167(11):6225-31.
10Mackay F,Mackay CR.The role of BAFF in B-cell maturation,T-cell activation and autoimmunity[J].Trends Immunol,2002;23(3):113-5.
